Palmstedt E, Mansson M, Hugosson J, Arnsrud Godtman R, et al. Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GOTEBORG-1 Trial. Eur Urol 2025 Jun 25:S0302-2838(25)00358-6. doi: 10.1016/j.eururo.2025.
PMID: 40571442